Cambridge Nutritional Sciences plc
CNSL.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -12.62% | 6.61% | -7.06% | 14.63% |
| EV / EBITDA | -59.25 | 1.32 | 36.06 | 18.52 |
| Quality | ||||
| ROIC | -3.48% | -4.17% | -1.45% | 11.13% |
| Gross Margin | 61.84% | 60.08% | 60.09% | 56.53% |
| Cash Conversion Ratio | 1.85 | 0.32 | 2.47 | 3.30 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.92% | -0.81% | 0.96% | -2.31% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 50.86 | -2.18 | -36.70 | -9.77 |
| Interest Coverage | -56.14 | -62.13 | -19.78 | -17.60 |
| Efficiency | ||||
| Inventory Turnover | 2.02 | 2.02 | 2.13 | 3.47 |
| Cash Conversion Cycle | 12.99 | -19.22 | 24.78 | 31.46 |